Dr. Luis E. Fayad MD Hematologist

Dr. Luis Fayad is a hematologist in Houston, Texas and is affiliated with University of Texas M.D. Anderson Cancer Center. He received his medical degree from Universidad Catolica de Santiago de Guayaquil and has been in practice for 29 years. He is one of 44 doctors at University of Texas M.D. Anderson Cancer Center who specialize in Hematology.

Are you Dr. Luis Fayad? Claim your profile to make edits or add details. Claim/Edit Profile

Office Location

See Contact Information

Specialty & Clinical Interests

Hematologist: General Hematology

Hospital Affiliation

University of Texas M.D. Anderson Cancer Center
Ranked #1 in Cancer

Education & Medical Training

Jackson Memorial Hospital/Jackson Health System
Residency, Internal Medicine, 1990 - 1993

University of Texas at Houston
Fellowship, Hematology, 1993 - 1994

University of Texas at Houston
Fellowship, Medical Oncology, 1994 - 1997

Universidad Catolica de Santiago de Guayaquil
Class of 1985

Certifications & Licensure

American Board of Internal Medicine
Certified in Hematology

American Board of Internal Medicine
Certified in Internal Medicine

American Board of Internal Medicine
Certified in Medical Oncology

IN State Medical License
Active through 2013

ME State Medical License
Active through 2013

ND State Medical License
Active through 2013

Publications & Presentations

Safety and activity of PD1 blockade by pidilizumab in combination with rituximab in patients with relapsed follicular lymphoma: a single group, open-label, phase 2 trial.
Westin, J. R.,Chu, F.,Zhang, M.,Fayad, L. E.,Kwak, L. W.,Fowler, N.,Romaguera, J.,Hagemeister, F.,Fanale, M.,Samaniego, F.,Feng, L.,Baladandayuthapani, V.,Wang, Z.,Ma, W.,Gao, Y.,Wallace, M.,Vence, L. M.,Radvanyi, L.,Muzzafar, T.,Rotem-Yehudar, R.,Davis, R. E.,Neelapu, S. S.

The prognostic value of interim positron emission tomography scan in patients with classical Hodgkin lymphoma.
Oki, Y.,Chuang, H.,Chasen, B.,Jessop, A.,Pan, T.,Fanale, M.,Dabaja, B.,Fowler, N.,Romaguera, J.,Fayad, L.,Hagemeister, F.,Alma Rodriguez, M.,Neelapu, S.,Samaniego, F.,Kwak, L.,Younes, A.

Could treatment with R-HCVAD/R-MA as compared to R- CHOP truly result in improved outcomes for patients with high-risk diffuse large B cell lymphoma? - Response to Landsburg et al.
Westin, J.,Oki, Y.,Fayad, L.

See all 40 publications

Insurances Accepted

  • Aetna Choice POS II
  • Aetna HMO
  • BCBS Blue Card PPO
  • BCBS Florida BlueSelect
  • BCBS Florida NetworkBlue
  • BCBS Florida Preferred Patient Care PPO
  • CareFirst BCBS Maryland POS
  • CareFirst BlueChoice Advantage
  • CareFirst BlueChoice Network POS
  • CareFirst BluePreferred PPO
  • CIGNA HMO
  • CIGNA Open Access
  • CIGNA PPO
  • First Health PPO
  • Great West PPO
  • Humana ChoiceCare Network PPO
  • United - River Valley Neighborhood Health Partnership
  • United Healthcare - Direct Choice Plus POS
  • United Healthcare - Direct Options PPO
Find More Doctors
Doctor Finder

Our Doctor Finder includes most U.S. physicians. Doctors are not ranked, learn more.

Browse Doctors by

Specialty

Location

Search all Doctors

Profiles by Doximity

Your Message Has Been Submitted

As part of our research on the correction you submitted, you may be contacted at the email address provided.

Sorry, Your Message Could Not Be Submitted

Please try again later, or E-mail your message to doctors@usnews.com and include the Web address (URL) of the page that contains incorrect information.